ODT
Odonate Therapeutics, Inc.
CEO and 10% owner Kevin C Tang bought $2.1M of Odonate Therapeutics, Inc.
Bought$2,087,457
$27.36Price
76,308Shares
+1%Stake
What ODT did for a copier
Prices for ODT after this filing aren't in yet.
Kevin C Tang's record
6 other buys with 3 months of prices since 2016: on average +1.2% against the S&P 500, and 2 of 6 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Jun 6. Filed Mon, Jun 10, 3:15 PM ET, during the session. Not investment advice.